ArticleNature communications2026
GLM-Prior: a genomic language model for transferable sequence-derived priors in gene regulatory network inference.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gene regulatory network inference depends on high-quality prior knowledge, yet curated priors are often incomplete or unavailable across species and cell types. We present GLM-Prior, a genomic language model fine-tuned to predict transcription factor-target gene interactions from nucleotide sequence. We integrate GLM-Prior with PMF-GRN in a dual-stage pipeline that combines sequence-derived priors with single-cell expression data for prior-conditioned GRN inference. Across six cell-line contexts, GLM-Prior performance scales with positive label abundance and TF coverage, showing above-chance agreement with reference networks in well-annotated mammalian settings. Single-species, species-transfer, and multi-species training show that GLM-Prior can construct informative priors across related mammalian species. Compared with accessibility-based priors, GLM-Prior achieves the highest prior performance in four of five mammalian cell lines. These benchmarks show that prior quality largely constrains GRN inference performance, positioning GLM-Prior as a transferable workflow for sequence-derived prior construction when matched experimental assays are unavailable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.